INTRODUCTION
Early in the HIV pandemic anaemia was identified as the most common haematological complication in HIV-infected adults 1 and a positive association had been reported between the prevalence of anaemia and severity of clinical disease 2 . Subsequently anaemia has been repeatedly identified as a strong, independent and reversible predictor of mortality in large studies of adults in western settings [3] [4] [5] .
The highest prevalence of HIV and anaemia occurs in tropical countries where over 60% of individuals with these conditions are women and children 6;7 . Current knowledge about HIV-related anaemia is predominantly based on studies in western men and may not be applicable to children in resource poor settings because of differences in epidemiology and aetiology 6;7 .
Anaemia in HIV-infected adults results primarily from reduced production of erythrocytes [8] [9] [10] [11] . This reduction is believed to be mediated by alterations in the secretion of cytokines and erythropoietin, and to be influenced by infection, neoplasms, drug toxicity and nutritional deficiencies. There is also a direct effect of HIV on erythropoiesis [8] [9] [10] [11] . In vitro data suggest that increased dyserythropoiesis and apoptosis of erythroid cells caused by HIV may play an important role 2;12;13 .
Compared to adults there is very little information available about HIV-associated anaemia in children. Only a few studies have assessed erythropoiesis and haematological findings in HIV-infected children [14] [15] [16] [17] and these studies were either retrospective 14;16;17 or lacked a control population for comparison [15] [16] [17] . Published studies used light microscopy but not flow cytometry which can provide information about the early stages of erythropoiesis, and none was undertaken in sub-Saharan Africa.
We have previously reported that HIV infection was more common among severely anaemic Malawian children than in a carefully selected control population (13% vs. 6%, p<0.001) 18 . HIV was strongly associated with severe anaemia after adjusting for confounding factors and red cell production failure appeared to be the primary mechanism 18 . The aim of the present study was to determine in severely anaemic Malawian children if HIV infection was associated with reduced erythroid precursor cells, or increased rates of apoptosis and dyserythropoiesis. A further objective was to study the role of cytokines, erythropoietin and plasma vitamin A related to these cellular mechanisms.
MATERIALS & METHODS

Population
The study was conducted in southern Malawi at Queen Elizabeth Central hospital in Blantyre (urban site) and Chikwawa District hospital (rural site) between July 2002 and July 2004. All children with a primary diagnosis of severe anaemia, defined as a blood haemoglobin concentration (Hb) less than 5 g/dl, were consecutively recruited into a prospective study. Inclusion criteria were: age 6-60 months, no blood transfusion within the previous month and informed consent from a parent or guardian. The study was approved by the Ethics Committees of the College of Medicine, Malawi, and the Liverpool School of Tropical Medicine, UK.
Procedures
This study was part of a large case-control study investigating the aetiology of severe anaemia in Malawian children and the admission and clinical management procedures have been described elsewhere 18 . In summary, on enrolment, a standardized study questionnaire and physical examination were completed, and peripheral blood samples were collected. If the clinical condition permitted, a fine needle bone marrow aspirate was obtained under local anaesthesia from the posterior superior iliac spine. Patients were treated in a study ward and all conditions were managed according to standard protocols. Nutritional Z-scores (weight-for-height) were calculated in EPI info 2000 19 and 'wasting' was defined as a Z-score <-2.
Laboratory measurements
Routine laboratory tests (haematology, bacteriology and parasitology) were performed within 24 hours and serum and plasma aliquots were stored at -80°C for later analysis. Laboratory staff were unaware of children's HIV status.
a) Haematology
Whole blood haemoglobin concentration was measured on site using the HaemoCue system (Angelholm, Sweden). A full blood count, including reticulocytes, was performed by Coulter counter analyzer (Beckman Coulter, Durban, South Africa). Bone marrow aspirate smears were stained with May-Grüwald-Giemsa for differential counting and myeloid:erythroid ratio 20 assessment. Dyserythropoiesis was defined by the presence of one or more of the following features: (a) multinuclearity; (b) karyorrhexis; (c) intercellular chromatin bridging; (d) incomplete mitoses 21 . Two hundred cells were counted and the number of dyserythropoietic cells were expressed as a percentage of all red cell precursors. b) Chemistry, microbiology and parasitology C-reactive protein (CRP) and erythropoietin were determined using a Roche p800/ e170 system (Roche, Switzerland). Inflammatory cytokine profiles were measured by Cytometric Bead Array on a FACS-Calibur flow-cytometer (FACS-Calibur, BD Biosciences, Franklin Lakes, USA). Serum vitamin A (retinol) was measured using high performance liquid chromatography 22 . Malaria slides were read by two independent readers, with a third reader resolving discrepant results. Malaria infection was defined as the presence of any asexual P. falciparum parasites in a thick blood film. HIV testing was performed using two rapid tests (Determine, Abbott-Laboratories, Japan; Unigold, Trinity-Biotech, Ireland). Reactive results in children less than 18 months and all discordant results were resolved by PCR 23 .
c) Flow cytometry
Bone marrow aspirates were processed within 24 hours, an automated cell count (Coulter counter) was followed by flow cytometry to determine the proportion of erythropoietic cells at different stages of maturation and to quantify the percentage of apoptotic cells. Bone marrow cells were separated using Ficoll-Paque (Pharmacia Biotech Uppsala, Sweden) and incubated with different combinations of the following antibodies and dyes: CD14-PE-Cy5 (Tük4), CD34-FITC and PE (QBEND/10), CD36-PE (CLB-IVC7), CD235a-FITC (CLB-AME-1) (Sanquin Reagents, Amsterdam, The Netherlands), Laser Dye Styril-751 (LDS, Applied Laser Technology Ltd, Maarheeze, The Netherlands), and Annexin V and Propidium iodide (IQ products, Groningen, the Netherlands) 24 . Cells were read by a four colour flow cytometer adapted with a 488-nm argon laser and a 633-nm red diode laser (FACSCalibur, BD Biosciences, Franklin Lakes, USA). Cell Quest Pro™ software (BD Biosciences, Franklin Lakes, USA), was used for cell acquisition and analysis. Acquisition was stopped after 50,000 events were detected within a predetermined gate for mononuclear cells, and information on cells was collected for analysis. For each patient, gates were applied twice according to a predefined protocol, by a reader (JCJC) who was blinded for patient characteristics.
CD34+ haematopoietic progenitors were defined as all mononuclear bone marrow cells expressing CD34 ( Figure 1) ; Erythroid progenitor cells were defined as mononuclear bone marrow cells expressing CD34 and CD36 but not CD14; the more mature Erythroid precursor cells were defined as all mononuclear bone marrow cells positively stained with LDS-751 (a DNA dye) and expressing CD235a (Glycoprotein A). Apoptosis was assessed in mononuclear bone marrow cells expressing CD235a. Early apoptosis was defined if cells expressed phosphatidylserine but not propidium idodide whilst in late apoptosis cells expressed both phosphatidylserine expression and propidium iodide. In viable cells neither of these markers was detected 24 .
Statistical methods
Patient characteristics and haematological variables were compared between HIVinfected and uninfected children using Chi-square and Fisher exact test for categorical data, or student t (normal distribution) and Mann-Whitney U tests (skewed distribution) for continuous variables. Correlations were assessed using Pearson or Spearman correlation coefficients, when appropriate A two-sided significance level was set at p= 0.05. In view of the explorative nature of this study we did not statistically adjust for multiple comparisons 25 . All analyses were preformed in SPSS 12 (SPSS, IL).
Reasons for not collecting bone marrow samples or performing HIV tests were: severe clinical condition of the child, death prior to collection of samples and no consent (HIV testing only). Basic data, disease prevalence and red cell statistics are presented per study group. Wasting was defined as a weight for height Z-score of less than -2 19 . IQR: Inter-Quartile Range; CRP: C-Reactive Protein; Table 2 . Haematological parameters in HIV-infected and uninfected children with severe anaemia using automated counts. 
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RESULTS
381 severely anaemic children were enrolled in the study 18 and complete data were available for 329 (Figure 2 ). Children were excluded if bone marrow samples or HIV tests were not available or bone marrow quality was poor which was not different amongst HIVinfected and uninfected children (p=0.37). Reasons for not collecting these data were: severe clinical condition of the child, death prior to collection of samples and no consent (HIV testing only). Of the remaining 329 children, 40 (12%) were infected with HIV and their median age was 25 months compared to 16 months for HIV-uninfected children (p<0.01). No significant differences between HIV-infected and uninfected children with regard to gender, wasting, malaria infection and a raised CRP (>10mg/L, Table 1 ). There were no differences in mean haemoglobin levels (p=0.67) or other erythrocytic indices between both groups (Table 2) .
Bone marrow microscopy identified a decreased myeloid/erythroid ratio (<2.0:1) in 85% of HIV-infected and 74% of HIV-uninfected children (p=0.16). Flow cytometric analysis revealed that HIV-infected children had fewer bone marrow CD34+ haematopoietic progenitors, erythroid progenitor cells and erythroid precursor cells when compared with HIV-uninfected children (Table 3 ). In HIV-infected and uninfected children, nucleated bone marrow cells identified by microscopy as pro-erythroblasts, basophilic erythroblasts and polychromatic erythroblast were similar in the two groups (Table 3) . Peripheral blood reticulocyte counts were also similar between HIV-infected and uninfected children (median 58.6 and 52.6 x10 9 /L, p=0.85). Although HIV-infected children were on average 9 months older than uninfected children in this study, correction for age did not alter the associations found (data not displayed).
Dyserythropoietic features were observed in 2.8% and 3.8% of erythroid precursors in HIV-infected and uninfected children respectively (p=0.12, Table 3 ). The proportions of erythroid precursor cells that were viable and those that were in various stages of apoptosis were similar between the two groups of children (Table 3 
DISCUSSION
This study is the first detailed prospective analysis of erythropoiesis using bone marrow samples and flow cytometry in HIV-infected children with severe anaemia. HIV infection was associated with decreased numbers of CD34+ haematopoietic progenitors and early progenitor cells, but normal numbers of later erythropoietic cells.
Although both HIV and anaemia occur frequently in children in tropical countries, and have been found to be associated with a high morbidity and mortality 26 , there have been few published studies of the pathogenesis of anaemia in HIV-infected children.
Circumstantial evidence suggests that, as in adults, red cell production failure is a more important cause of anaemia in HIV-infected children than blood loss 14-17;27-29 or haemolysis 14;17;30-32 . Bone marrow examinations have rarely been carried out in HIVinfected children and most data about anaemia have been derived from retrospective analyses of hospital records which did not include a control group 14-17;27 .
In this group of severely anaemic children, HIV-infected individuals were found to have fewer CD34+ haematopoietic progenitors and erythroid progenitor cells in the bone marrow than children without HIV. This supports the hypothesis that red cell production failure is an important cause of severe anaemia in HIV-infected children and may be caused by a reduced CD34+ haematopoietic progenitor capacity 33 . Despite the difference in CD34+ haematopoietic progenitors and erythroid progenitors the proportion of more mature erythroid precursor cells in bone marrow or peripheral blood (reticulocytes) did not differ between the two groups. Hence HIV-uninfected children with severe anaemia appeared to be less productive or efficient in their (subsequent) erythropoiesis than HIV-infected children. This explanation is supported by the trend towards less dyserythropoiesis and apoptosis in HIV-infected children. A finding which is in contrast to other studies which reported dyserythropoiesis more commonly in later stages of HIV disease and concluded that anaemia may related to increased dyserythropoiesis 2;14 .
HIV infection affects haematopoietic processes 34 , including CD34+ haematopoietic progenitor differentiation, possibly through abnormal expression of cellular genes and cytokines that influence haemopoiesis and especially the African strain of HIV (1C) can directly infect CD34+ haematopoietic progenitors 35 . In this study dyserythropoiesis or apoptosis were not associated with altered cytokine levels in contrast to other reports 30;36 . Vitamin A deficiency has been associated previously with apoptosis or dyserythropoiesis 37;38 , although this association was not observed in the present study despite the fact that 90% of children were deficient 18 . More intensive investigations might identify cytokines that may affect regulatory signals which could be therapeutic targets to reduce haemopoietic inhibition in HIV patients.
There were no differences in peripheral blood erythrocytic indices or bone marrow microscopy in HIV-infected compared to non-infected children. This confirms previous reports for Italian children 39 and American children 14 as well as adults [8] [9] [10] . The absence of differences using these common diagnostic tools may relate to the anaemia in these HIVinfected and uninfected children being multi-factorial in aetiology, as is so commonly observed in African children 18;26 .
The study results were not effected by anti-retroviral therapy (ART), known to exacerbate blood and bone marrow abnormalities 40 , as ART was not routinely available in Malawi at the time of the study. The fact that not all tests were done on all children is a study limitation, although the large sample size available increases confidence that the study sample was representative.
In conclusion the findings in these severely anaemic Malawian children indicate that despite an HIV-associated deficiency in early red-cell precursors, subsequent erythropoiesis is at least as efficient in HIV-infected as in HIV-uninfected children with severe anaemia.
